Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms.

• DOI: 10.1037/a0017939
• Publication Date: 2010-01-26T15:29:40Z
• Authors: Laura MacPherson; Matthew T. Tull; Alexis K. Matusie...; Samantha Rodman; David R. Strong; Christopher W. Ka...; Derek R. Hopko; Michael J. Zvolensky; Richard A. Brown; C. W. Lejuez
• Keywords: Nicotine replacement therapy; Depression; Behavioral Activation

Depressive symptoms are associated with poor smoking cessation outcomes, and there remains continued interest in behavioral interventions that simultaneously target depressive symptomatology. In this pilot study, we examined whether a activation treatment for (BATS) can enhance outcomes. A sample of 68 adult smokers mildly elevated (M = 43.8 years age; 48.5% were women; 72.7% African American) seeking randomized to receive either BATS paired standard (ST) strategies including nicotine replacement therapy (n 35) or ST alone 33). matched contact time included 8 sessions group-based treatment. Quit date was assigned occur at Session 4 each condition. Participants completed baseline assessment; furthermore, measures outcomes (7-day verified point-prevalence abstinence), (Beck Depression Inventory-II; Beck, Steer, & Brown, 1996), enjoyment from daily activities (Environmental Reward Observation Scale; Armento Hopko, 2007) obtained 1, 4, 16, 26 weeks post quit date. Across the follow-ups over weeks, participants reported greater abstinence (adjusted odds ratio 3.59, 95% CI [1.22, 10.53], p .02) than did those ST. also reduction (B -1.99, SE 0.86, Results suggest is promising intervention may promote improve among underserved diverse backgrounds.